STAGE IIIB HEPATOCELLULAR CARCINOMA AJCC V8
Clinical trials for STAGE IIIB HEPATOCELLULAR CARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIB HEPATOCELLULAR CARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIIB HEPATOCELLULAR CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare liver cancer: Triple-Drug attack shows promise
Disease control Recruiting nowThis study tests a combination of three drugs—nivolumab (an immunotherapy), fluorouracil (chemotherapy), and interferon alpha-2b (an immune booster)—in people with a rare type of liver cancer called fibrolamellar carcinoma that cannot be surgically removed. The goal is to see if …
Matched conditions: STAGE IIIB HEPATOCELLULAR CARCINOMA AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 03:33 UTC
-
Electric field therapy worn like a vest shows promise against tough cancers
Disease control Recruiting nowThis early-phase study tests a wearable device that creates low-intensity electric fields to disrupt cancer cell growth, combined with standard drugs (cabozantinib or nab-paclitaxel plus atezolizumab). About 43 adults with advanced solid tumors in the abdomen or chest that have s…
Matched conditions: STAGE IIIB HEPATOCELLULAR CARCINOMA AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 03:28 UTC
-
New hope for liver cancer: combo therapy tested after first treatment fails
Disease control Recruiting nowThis study tests whether adding an immunotherapy drug (atezolizumab) to a standard targeted therapy (cabozantinib or lenvatinib) works better than the targeted therapy alone for people with advanced liver cancer that cannot be surgically removed and has already been treated with …
Matched conditions: STAGE IIIB HEPATOCELLULAR CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated May 26, 2026 02:48 UTC
-
Custom-Made cancer vaccine shows promise in advanced tumors
Disease control Recruiting nowThis study tests a personalized vaccine made from a patient's own tumor proteins, combined with the immunotherapy drug pembrolizumab, for people with advanced solid tumors (like breast, lung, or skin cancer). The goal is to see if the combination is safe and helps the immune syst…
Matched conditions: STAGE IIIB HEPATOCELLULAR CARCINOMA AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New drug combo after radiation shows promise for advanced liver cancer
Disease control Recruiting nowThis study tests whether adding immunotherapy drugs (durvalumab with or without tremelimumab) after standard radiation therapy can help control advanced liver cancer that has spread. About 21 adults whose cancer has worsened despite prior treatment will receive radiation followed…
Matched conditions: STAGE IIIB HEPATOCELLULAR CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: Mary Feng, MD • Aim: Disease control
Last updated May 22, 2026 13:50 UTC